Microbe of the Week is written by undergraduate researcher Maria Bergquist
Microbe of the Week: Tick-Borne Encephalitis
Welcome to microbe of the week, where we break down the
different disease-causing microbes that lurk inside our tick vectors! This
week’s microbe is
Tick-Borne Encephalitis virus, which causes Tick-Borne
Encephalitis (TBE).
What is the TBE virus?
Tick-borne encephalitis is a viral infection that
specifically targets the central nervous system. TBE virus is from the genus
flavivirus, the same genus that houses diseases like West Nile virus and Zika
virus. This virus is primarily found along the southern border of Russia into
eastern Europe but has also been found throughout other parts of Europe and
Asia. A similar virus under the same genus, Powassan virus, has been reported
in the United States.
The current known reservoir host for TBE virus is primarily small
rodents like voles and mice. TBE virus is transmitted to humans and other
animals by Ixodes ricinus in Europe and Ixodes persulcatus in Russia. TBE virus
may also be contracted by consuming unpasteurized dairy products from infected
animals.
Symptoms
The CDC reports symptoms of TBE as fever, achiness, loss of
appetite, headache, nausea, and vomiting. They note that swelling of the brain
and/or spinal cord, confusion, and sensory disturbances occur in 20-30% of cases.
Symptoms occur on average after seven days but have been reported taking up to
28 days post tick bite.
Treatment
There is no known cure for TBE or Powassan Virus Disease.
Medical intervention primarily involves symptom management, which is required
in cases of encephalitis. Vaccines for TBE are available in some endemic areas.
A Condensed History
- 1936 — TBE described as epidemic encephalitis along the border of Russia and Japan.
- 1937 — First isolation of TBE virus lead by Russian Virologist Lev Zilber.
- 1941 — First vaccine for TBE developed.
- 1970 — First case of Powassan virus discovered in the US.
- 2019 — Reported cases of TBE range from 5,000 to 13,000 per year.
No comments:
Post a Comment